Current Progressive Cattle digital edition

Norbrook releases Hexasol Injection antibiotic

Norbrook Laboratories, Ltd. Published on 28 February 2011

Norbrook Laboratories, Ltd. announces the introduction of Hexasol Injection, the only medication on the U.S. market that combines the long-acting antibiotic oxytetracycline (active ingredient in Noromycin™ 300 LA & 300 PRO LA™) and the non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine in one convenient dose.

0311pc_np_norbrook_1Hexasol Injection is indicated for the treatment of bacterial pneumonia associated with Pasteurella spp. and for the control of associated pyrexia (fever) in beef and non-lactating dairy cattle.

The dual-action formulation of Hexasol Injection offers veterinarians and cattle producers a practical choice when combined antibiotic and antipyretic action is indicated.

Key attributes of Hexasol Injection include proven safe and effective ingredients, the convenience of a SQ or IM dosing option and a relatively short withdrawal time prior to slaughter of 21 days.

All presented at lower dose volume, and more economically, than competitive products with combined antibiotic and antipyretic ingredients.

Hexasol Injection is available by prescription only.

—Norbrook press release

Hexasol Injection combines an antibiotic and non-steroidal anti-inflammatory drug in one convenient dose.
Photo courtesy Norbrook.